A Nevada inmate slated to die by a three-drug lethal injection combination never before used in the U.S. has said repeatedly he wants his sentence carried out and he doesn’t care if it’s painful.

A Nevada inmate slated to die by a three-drug lethal injection combination never before used in the U.S. has said repeatedly he wants his sentence carried out and he doesn’t care if it’s painful.

But a last-minute lawsuit filed by a drug company that doesn’t want its product used in “botched” executions could derail Scott Raymond Dozier’s scheduled Wednesday execution.

New Jersey-based Alvogen filed court documents Tuesday saying Nevada prison officials illegally obtained the sedative midazolam and demanding it be returned and not used in Dozier’s execution.

“Midazolam is not approved for use in such an application,” the document said, adding uses of midazolam in other states “have been extremely controversial and have led to widespread concern that prisoners have been exposed to cruel and unusual treatment.”

Clark County District Judge Elizabeth Gonzalez scheduled a hearing Wednesday to decide if the execution can take place just hours later. A Nevada prisons spokeswoman did not comment.

Midazolam was substituted in May for expired prison stocks of diazepam, a similar sedative commonly known as Valium. Nevada’s first-of-its-kind plan also calls for the powerful synthetic opioid fentanyl to slow Dozier’s breathing and the muscle paralytic cisatracurium to prevent movement and stop his breathing.

Nevada refused Pfizer’s demand last year to return the company’s diazepam and fentanyl, which has been blamed for overdoses nationwide but has not been used in an execution.

Pharmaceutical companies have been resisting the use of their drugs in executions for 10 years, citing both legal and ethical concerns, but McKesson Corp. became the first company to sue in the U.S. last year over use of its product in an Arkansas execution, said Robert …read more

Source:: New Jersey Real -Time News

      

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *